ambien sound machine

phentermine 40 mg

"We are pleased that the FDA has granted approval of Multaq for patients in a therapeutic area that has seen few new treatment options in the last twenty years," said Marc Cluzel, MD, Senior Vice President, Research and Development, sanofi-aventis. It is emerging as a public health concern and affects about 2.D., Professor of Medicine & Director, Division of Cardiology, McMaster University, Hamilton, Canada, and co-principal investigator in the ATHENA study.027]. ambien sound machine "Based on clinical studies, Multaq reduces the risk of cardiovascular hospitalizations in patients with atrial fibrillation / atrial flutter, this outcome could change the way we approach the management of the disease. ambien sound machine " The incidence of atrial fibrillation is growing worldwide in relation to aging populations. The patients enrolled in ANDROMEDA had relatively severe heart failure and had been hospitalized, or referred to a specialty heart failure clinic for worsening symptoms. xanax amount management anxiety

In contrast, in ATHENA, all patients had a history of AF/AFL, and 71% of patients had no heart failure, 25% were NYHA class I or II, and only 4% were class III. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. and represents one-third of hospitalizations for arrhythmia in Europe. ambien sound machine The risk mitigation program consists of a Communication Plan for HCPs, a medication guide for patients and post-marketing surveillance. ambien sound machine About dronedarone (Multaq) Multaq, discovered and developed by sanofi-aventis, is one of the major therapeutic innovations in patients with atrial fibrillation in the last twenty years. buy mg phentermine

The mPACT(TM) Partnership was developed to assist healthcare professionals (HCPs) with the identification of appropriate patients and to ensure the safe use of Multaq while minimizing risk.D. Atrial fibrillation is a complex disease that increases the risk of stroke up to five-fold, worsens the prognosis of patients with cardiovascular risk factors, and doubles the risk of mortality. ambien sound machine Multaq is the first drug approved in the United States that has shown a clinical benefit to reduce cardiovascular hospitalization in patients with AF/AFL. About sanofi-aventis Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. ambien sound machine Atrial fibrillation is a potentially life-threatening condition, with significant burden on patients, health care providers and payers.